trenbolone acetate has been researched along with Osteoporosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balaez, A; Beck, DT; Beggs, LA; Borst, SE; Combs, SM; Conover, CF; Lachacz, SA; Leeper, AM; Miller, JR; Otzel, DM; Williams, AA; Wronski, TJ; Yarrow, JF; Ye, F; Zheng, N | 1 |
Beck, BR; Donner, DG; Du Toit, EF; Elliott, GE; Forwood, MR | 1 |
2 other study(ies) available for trenbolone acetate and Osteoporosis
Article | Year |
---|---|
Influence of aromatase inhibition on the bone-protective effects of testosterone.
Topics: Anabolic Agents; Anastrozole; Androgens; Animals; Aromatase; Aromatase Inhibitors; Heptanoates; Male; Muscle, Skeletal; Nitriles; Orchiectomy; Osteoporosis; Rats; Rats, Inbred F344; Testosterone; Trenbolone Acetate; Triazoles | 2014 |
The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
Topics: Absorptiometry, Photon; Anabolic Agents; Animal Nutritional Physiological Phenomena; Animals; Biomechanical Phenomena; Body Composition; Bone Density; Bone Density Conservation Agents; Diet; Disease Models, Animal; Drug Evaluation, Preclinical; Femur; Male; Obesity, Abdominal; Orchiectomy; Osteoporosis; Random Allocation; Rats, Wistar; Risk Factors; Testosterone; Trenbolone Acetate | 2016 |